SG
THC icon

Societe Generale’s Tenet Healthcare THC Stock Holding History

Societe Generale’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$2.16M Buy
+78,237
New +$2.31M 0.02% 798

Other funds holding THC

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Societe Generale's THC Position: Q2 2016 in Review

Societe Generale opened a new position in Tenet Healthcare (THC) in Q2 2016: 78,237 shares worth $2.16M. The stake represents 0.02% of the portfolio and ranks #798 among its holdings.

261 funds tracked by Wall St. Rank hold THC as of Q2 2016.

  • Societe Generale held 78,237 shares of Tenet Healthcare worth $2.16M as of Q2 2016.
  • Tenet Healthcare was a new Societe Generale position in Q2 2016.
  • Tenet Healthcare made up 0.02% of Societe Generale's portfolio in Q2 2016, its #798 holding.
  • 261 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.